Dr. Harris has extensive experience as a clinician, prescriber and drug developer. He has served as a clinical investigator for numerous dermatology NDAs and ANDAs and as a clinical advisor to multiple Contract Research Organizations. A board-certified dermatologist and a fellow of the American Society of Mohs Surgery (ASMS), Dr. Harris also has in-depth training in skin cancer treatment, wound healing and cosmetic procedures. Dr. Harris graduated from Florida State University and obtained his doctorate from the University of Florida Medical School. He trained at the Mayo Clinic in Rochester, MN, before completing his dermatology residency at the University of Miami. To view publications by Dr. Harris, Click Here
Janice has a comprehensive background in healthcare administration, drug development and business operations. She has served as director for dermatology NDA and ANDA clinical trials. In addition to management of Harris' financial operations, Janice directs and oversees Harris' product portfolio, including new product development and pipeline activities. Janice holds a BS in Finance and a BS in Accounting from Florida State University and the Florida Certified Public Accountant License.
Susan joined Harris Pharmaceutical in May 2017 as Vice President and is responsible for corporate strategy, business development, and overseeing commercial business operations. Previously, Susan held finance leadership roles and acted as a business partner to various functional teams supporting research and development, sales and marketing, global planning and analysis, treasury and investor relations. Susan holds a Bachelor of Arts in Biology and a Masters in Business Administration in Finance from the University of Texas at Arlington.
Rob joined Harris Pharmaceutical in October 2017 as a Director and is responsible for commercial and operational planning, business development, and financial analysis. Previously, Rob led an Analytics Team and various Finance lead roles supporting Branded and Generic products, Sales and Marketing Teams, and portfolio optimization analysis. Rob holds a Bachelor of Science in Accounting from Rutgers University and is a Certified Public Accountant.
Susan's 35 years experience in the pharmaceutical industry includes Pharmaceutical Research and Development and Regulatory Affairs. She specializes in the Chemistry, Manufacturing, and Controls area of Regulatory Affairs. Susan was previously employed with Burroughs Wellcome.
Selma brings over 25 years experience in Product Development and Quality, and has held directorship and lead management positions in multiple generic and contract manufacturing pharmaceutical and biotech companies. She is responsible for Harris' Quality Affairs and CMC.